96 related articles for article (PubMed ID: 2973992)
1. Heparan sulphate with no affinity for antithrombin III and the control of haemostasis.
Scully MF; Ellis V; Kakkar VV
FEBS Lett; 1988 Dec; 241(1-2):11-4. PubMed ID: 2973992
[TBL] [Abstract][Full Text] [Related]
2. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
Scully MF; Ellis V; Shah N; Kakkar V
Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
[TBL] [Abstract][Full Text] [Related]
5. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
Carlson TH; Kolman MR; Piepkorn M
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant properties in vitro of heparan sulphates.
Hubbard AR; Jennings CA; Barrowcliffe TW
Thromb Res; 1984 Sep; 35(5):567-76. PubMed ID: 6237461
[TBL] [Abstract][Full Text] [Related]
7. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
Larsson A; Fransson LA; Lewis WE
Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
[TBL] [Abstract][Full Text] [Related]
9. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
[TBL] [Abstract][Full Text] [Related]
10. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
Schoen P; Wielders S; Petitou M; Lindhout T
Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypoxia on heparan sulfate in bovine aortic and pulmonary artery endothelial cells.
Karlinsky JB; Rounds S; Farber HW
Circ Res; 1992 Oct; 71(4):782-9. PubMed ID: 1516155
[TBL] [Abstract][Full Text] [Related]
13. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
14. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
Hovingh P; Piepkorn M; Linker A
Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
[TBL] [Abstract][Full Text] [Related]
15. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys.
Absher E; Labarrere CA; Carter C; Haag B; Faulk WP
Transplantation; 1992 Apr; 53(4):828-34. PubMed ID: 1566349
[TBL] [Abstract][Full Text] [Related]
16. Anti-factor Xa activity of heparan sulphate.
Thomas DP; Merton RE; Barrowcliffe TW; Mulloy B; Johnson EA
Thromb Res; 1979; 14(2-3):501-6. PubMed ID: 155896
[No Abstract] [Full Text] [Related]
17. Affinity of the gastric pathogen Helicobacter pylori for the N-sulphated glycosaminoglycan heparan sulphate.
Ascencio F; Fransson LA; Wadström T
J Med Microbiol; 1993 Apr; 38(4):240-4. PubMed ID: 7682621
[TBL] [Abstract][Full Text] [Related]
18. [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells].
Nishinaga M; Shimada K
Rinsho Byori; 1994 Apr; 42(4):340-5. PubMed ID: 8176841
[TBL] [Abstract][Full Text] [Related]
19. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
[TBL] [Abstract][Full Text] [Related]
20. Structural features of the contact zones for heparan sulphate self-association.
Fransson LA
Carbohydr Res; 1982 Nov; 110(1):127-33. PubMed ID: 6216948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
